PHOtonic integrated OCT-enhanced flow cytometry for canceR and cardiovascular diagnostics enabled by Extracellular VEsicles discRimination
PHOREVER is a research and innovation action that aims to develop a disruptive multi-sensing platform with a great medical impact. The platform will enable for the first time the reliable detection of EVs with size down to 80 nm, the detection of EVs with specific biomarkers (proteins) on their surface, and the calculation of the corresponding EV concentrations in the blood while data analysis empowered by artificial intelligence will correlate the measurement data to disease specific medical information.
We are thrilled to announce the participation of the PHOREVER Project in the workshop “Transformation of the Health Care Delivery through e/m Health Services” at
Excited to share that the 1st Period Review Meeting of the PHOREVER Project took place online on June 3, 2024. The meeting was successful, highlighting
Topic: HORIZON-CL4-2022-DIGITAL-EMERGING-01-03 – Advanced multi-sensing systems (Photonics Partnership) (RIA)
Programme Call: HORIZON-CL4-2022-DIGITAL-EMERGING-01
Project number: 101093171
Start date: 1 January 2023
Duration: 42 months
EU contribution: € 4 973 882,50
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
